Doc, I suspect that Joe believes (hopefully can prove) that Alpha is behind the downward pressure on the pps. One of the Nasdaq listing requirements is a pps of $4 (IIRC) - when GNBT was making that run beyond $3 a couple of weeks ago, that looked like a certainty. But then it hit a wall and has fallen since (now fluctuating in its current range). If Alpha was behind that wall and did it so it could claim the breech and repayment, then they artificially created the scenario where GNBT cannot pursue uplisting for their benefit and at GNBT's cost (ie, shareholder's cost).
I can't think of any other method that Alpha could have affected GNBT's ability to uplist. Thoughts on what I'm missing?
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links